Status:
COMPLETED
Management of Patent Ductus in Premature Infants
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Defect, Congenital Heart
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE3
Brief Summary
To evaluate the effects (up to one year of age) of indomethacin on the clinical course of patent ductus arteriosus (PDA) in premature infants (24 hours old or less) and to assess the relative merits o...
Detailed Description
BACKGROUND: The incidence of patent ductus arteriosus is higher in premature infants than in full-term infants and is highest in premature infants who have respiratory distress syndrome. It is genera...
Eligibility Criteria
Boy and girl premature infants with patent ductus arteriosus. Birth weight of 1,750 grams or less. Admitted to participating institution within first 24 hours of life.
Key Trial Info
Start Date :
September 1 1978
Trial Type :
INTERVENTIONAL
End Date :
March 1 1982
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000494
Start Date
September 1 1978
End Date
March 1 1982
Last Update
December 13 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.